Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Squamous Cell Carcinoma 11Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Lymphatic Metastasis 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Recurrence 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Paclitaxel 11Carboplatin 8Radiotherapy 6Cyclophosphamide 6Trastuzumab 5Chemotherapy, Adjuvant 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Epirubicin 3Doxorubicin 3Cryosurgery 3Cisplatin 3pertuzumab 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiation 2Letrozole 2Lapatinib 2Cryotherapy 2Brachytherapy 2talimogene laherparepvec 1sargramostim 1ferric carboxymaltose 1atezolizumab 1aldesleukin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Zoledronic Acid 1Vorinostat 1VPS Coriolus versicolor extract 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Ductal, Breast × TP protocol × Clear all
NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

RenJi Hospital

Phase 3 Recruiting
762 enrolled
Breast

Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡